Filter your results
- 4
- 1
- 5
- 5
- 1
- 1
- 2
- 1
- 5
- 5
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell LymphomaNew England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Journal articles
hal-02329536v1
|
||
Genomic characterization of metastatic breast cancersNature, 2019, 569 (7757), pp.560-564. ⟨10.1038/s41586-019-1056-z⟩
Journal articles
hal-02504838v1
|
|||
|
High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screeningCytometry Part B: Clinical Cytometry, 2018, 94 (5), pp.658-661. ⟨10.1002/cyto.b.21600⟩
Journal articles
hal-01812481v1
|
||
|
Pan-HDAC Inhibitors May Restore PRDM1 Expression in Follicular LymphomaBlood, 2018, 132 (Suppl 1), pp.2848. ⟨10.1182/blood-2018-99-113269⟩
Journal articles
hal-02076928v1
|
||
|
Dual role of EZH2 in megakaryocyte differentiationBlood, 2021, 138 (17), pp.1603-1614. ⟨10.1182/blood.2019004638⟩
Journal articles
hal-03447247v1
|